This bill amends the Organic Foods Production Act to require organic producers to confirm that soil or growing media contains no synthetic chemicals before planting. It directly affects organic farmers and wild crop harvesters by mandating pre-plant testing for prohibited substances, adding a new certification requirement for soil verification. Key provisions include inserting language requiring testing verification methods and directing the Secretary to develop guidelines within 60 days of enactment. The bill focuses on tightening certification standards for organic production, not increasing supply or demand.
The Opportunities in Organic Act establishes a new federal program to support farmers and ranchers transitioning to organic certification and expanding organic operations. It provides cost-share payments for organic certification (up to $1,500 per producer, with higher amounts allowed for socially disadvantaged farmers or in high-cost regions) and funds eligible nonprofits to deliver technical assistance, transition support, and supply chain development. The program specifically targets socially disadvantaged farmers, organic producers, and farms in vulnerable or under-resourced areas, with annual funding starting at $50 million for 2027-2028 and increasing to $100 million annually by 2030.
HR 7251, the "Prohibit Partisan Park Passes Act," amends federal law to prevent the use of living political figures on National Park Service and federal recreational lands passes. The bill specifically prohibits including images of current or former elected officials or other living political figures on these passes. This change directly affects the National Park Service, which issues the passes, and ensures the design remains neutral. The law modifies existing regulations under the Federal Lands Recreation Enhancement Act to remove partisan imagery from these commonly used visitor passes.
This bill would require colleges to demonstrate that at least 15% of their student loan borrowers successfully reduce their loan principal within two years of entering repayment, or risk losing eligibility for federal student loan programs starting in fiscal year 2028. It also creates a new bonus grant program for institutions with repayment rates above 25% and requires colleges to pay fees based on the amount of loans their students fail to repay. The legislation defines repayment success as borrowers who are not in default and have made at least a one-dollar reduction in their principal balance, while excluding students in deferment for military service, graduate school, or public service.
This bill establishes a federal task force to address maternal health disparities by coordinating efforts across multiple government agencies and community stakeholders to reduce preventable maternal deaths and serious health complications. The task force will include representatives from various departments such as Health and Human Services, Housing and Urban Development, and Transportation, along with community leaders, patients, and healthcare providers focused on maternal health. Additionally, the bill authorizes $100 million over five years to provide grants to community organizations for addressing social determinants of maternal health including housing, transportation, nutrition, employment, and environmental conditions. These grants prioritize areas with high rates of maternal mortality and poverty, and recipients must submit annual reports on their activities and outcomes. The legislation defines key terms such as maternal mortality and social determinants of maternal health to guide implementation and reporting requirements.
This bill, titled the Future of Artificial Intelligence Innovation Act of 2026, creates a new Center for Artificial Intelligence Standards and Innovation within the National Institute of Standards and Technology to develop voluntary testing standards, evaluation tools, and best practices for AI systems. The bill establishes testbed programs that allow companies of all sizes to access federal computing resources and facilities for testing AI technologies, while also creating international coalitions with like-minded countries to align on AI standards and security measures. It authorizes federal agencies to award prizes for solving specific AI challenges and requires a report identifying regulatory barriers that may hinder AI innovation. The legislation also expands hiring authority for technical experts and adds requirements for auditing temporary workers involved in AI research.
S 2903, the Safe Step Act, requires health insurance plans and employers offering health coverage to establish a clear, timely process for patients or doctors to request exceptions when step therapy protocols (where insurers require trying cheaper drugs first) would harm a patient. It mandates approval for exceptions if prior drugs failed, delay would cause severe harm, a drug is unsafe, or a patient is stable on their current medication. Plans must respond to requests within 72 hours (or 24 hours in emergencies) and cover the requested drug without extra cost-sharing. The bill also requires annual reports to the government on exception requests, approvals, denials, and trends by medical condition or specialty. This directly affects patients on health plans with step therapy, their doctors, and the insurers managing those plans.
S 2287, the Palliative Care and Hospice Education and Training Act, establishes federal funding to expand training for health professionals in palliative and hospice care. The bill creates multiple programs including grants for education programs, fellowships for faculty to gain specialized training, and career incentive awards for students pursuing palliative care specialties. It prioritizes training in rural and underserved areas, for pediatric populations, and for racial and ethnic minorities. The bill authorizes $15 million annually through 2030 to build a more skilled palliative care workforce for patients with serious or life-threatening illnesses.
This bill (S 1677, Ensuring Lasting Smiles Act) requires health insurance plans to cover medically necessary treatments for congenital anomalies or birth defects affecting the eyes, ears, teeth, mouth, or jaw. It mandates coverage for reconstructive services, dental/orthodontic care, and related treatments during the course of medical treatment, while excluding purely cosmetic procedures not medically necessary. Plans may apply cost-sharing requirements similar to those for other medical services but must provide notice about these coverage requirements to participants by January 1, 2026. The bill also directs a study on provider network adequacy and cost impacts related to these coverage requirements, to be completed by December 2027.
Resident Education Deferred Interest Act or the REDI Act This bill allows borrowers in medical or dental internships or residency programs to defer student loan payments until the completion of their programs.
The HELP Copays Act requires that financial assistance from non-profit organizations or prescription drug manufacturers counts toward patients' annual out-of-pocket cost-sharing limits (like deductibles and copays) for certain prescription drugs. It directly affects individuals enrolled in group health plans or individual insurance who receive such assistance, ensuring payments from these sources reduce their total out-of-pocket spending. The bill amends key healthcare laws to include these payments in calculating cost-sharing thresholds, specifically for specialty drugs and drugs subject to utilization management (like prior authorization). It takes effect for plan years beginning in 2026 and does not change how utilization management tools are applied.
This bill requires health insurance plans to cover prostate cancer screenings without copays or deductibles for men aged 40+ who are at high risk of prostate cancer. It specifically applies to African-American men and men with a family history of prostate cancer (defined as having a first-degree relative diagnosed with the disease or genetic risk factors). The law amends existing coverage requirements to include these screenings as a preventive service, aiming to address disparities in late-stage diagnosis and improve early detection rates. The policy change takes effect for plan years beginning January 1, 2025.
